| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/02/2004 | WO2004104550A2 Rapid and specific detection of enterobacter sakazakii |
| 12/02/2004 | WO2004104230A1 Reducing microarray variation with internal reference spots |
| 12/02/2004 | WO2004104229A2 Internal control nucleic acid molecule for nucleic acid amplification systems |
| 12/02/2004 | WO2004104228A1 Microfluidic protein crystallography |
| 12/02/2004 | WO2004104227A1 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 12/02/2004 | WO2004104226A1 Susceptibility gene for alzheimer's disease |
| 12/02/2004 | WO2004104225A1 Diagnosis and prediction of parkinson’s disease |
| 12/02/2004 | WO2004104224A2 Markers for lxr activation |
| 12/02/2004 | WO2004104223A1 Method for the covalent immobilisation of probe biomolecules on organic surfaces |
| 12/02/2004 | WO2004104220A2 Use of a biotinylated polypeptide for determining the activity of protein-phosphorylating enzymes |
| 12/02/2004 | WO2004104219A1 Mass-based toxin assay and substrates therefor |
| 12/02/2004 | WO2004104218A1 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1) |
| 12/02/2004 | WO2004104217A2 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 12/02/2004 | WO2004104216A2 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| 12/02/2004 | WO2004104215A2 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7) |
| 12/02/2004 | WO2004104214A2 Methods and devices for multiplexing amplification reactions |
| 12/02/2004 | WO2004104212A2 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis |
| 12/02/2004 | WO2004104211A2 Method for detecting toxic and non-toxic cyanobacteria |
| 12/02/2004 | WO2004104203A1 Method of measuring glycolated hemoglobin a1c, enzyme to be used therefor and process for producing the same |
| 12/02/2004 | WO2004104199A2 Modulation of gene expression using dna-dna hybrids |
| 12/02/2004 | WO2004104196A1 Buffer composition |
| 12/02/2004 | WO2004104189A1 New enterovirus, vaccines, medicaments and diagnostic kits |
| 12/02/2004 | WO2004104181A2 Nucleic acid processing methods, kits and devices |
| 12/02/2004 | WO2004104179A2 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment |
| 12/02/2004 | WO2004104177A2 Methods for localizing target molecules in a flowing fluid sample |
| 12/02/2004 | WO2004104176A2 Method for the identification of inhibitors of ornithine carbamoyltransferase, ketol-acid reductoisomerase, and fungal pathogenicity-conferring gene as antibiotics |
| 12/02/2004 | WO2004104172A2 Hybridization-mediated analysis of polymorphisms |
| 12/02/2004 | WO2004104171A2 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 12/02/2004 | WO2004104161A2 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 12/02/2004 | WO2004104070A1 Permselective structurally robust membrane material |
| 12/02/2004 | WO2004104037A1 Method for screening inhibitors of the gamma-secretase |
| 12/02/2004 | WO2004103939A2 Assay method and apparatus |
| 12/02/2004 | WO2004103547A1 Device for holding and detecting substance libraries |
| 12/02/2004 | WO2004103512A2 Method and system for electrokinetic, preparative sample separation in high-surface-area separation channels with non-convex cross sections |
| 12/02/2004 | WO2004103406A1 Therapeutic composition for disease accompanied by decrease or increase of platelet |
| 12/02/2004 | WO2004103368A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| 12/02/2004 | WO2004103316A2 Orp9, a novel therapeutic target for increasing hdl levels |
| 12/02/2004 | WO2004103269A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |
| 12/02/2004 | WO2004103268A2 Intracellular production of specific rna molecules by splicing |
| 12/02/2004 | WO2004092418A3 Global amplification using a randomly primed composite primer |
| 12/02/2004 | WO2004087868A3 Dna polymerase fusions and uses thereof |
| 12/02/2004 | WO2004087863A3 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 12/02/2004 | WO2004082569A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) |
| 12/02/2004 | WO2004081566A3 Method and device for detecting biomolecules |
| 12/02/2004 | WO2004081521A3 Methods for direct detection of individual methotrexate metabolites |
| 12/02/2004 | WO2004081174A3 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 12/02/2004 | WO2004079007A3 Time-lapse cell analysis method |
| 12/02/2004 | WO2004067768A3 Improved method for the detection of proteolytic enzymes |
| 12/02/2004 | WO2004067702B1 Methods, oligonucleotides and kits for the identification of mycobacterium in a sample |
| 12/02/2004 | WO2004058945A3 Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same |
| 12/02/2004 | WO2004050825A3 Protein synthesis monitoring (psm) |
| 12/02/2004 | WO2004044218A3 Methods and materials for examining pathways associated with glioblastoma progression |
| 12/02/2004 | WO2004044128A3 An associative analysis of gene expression array data |
| 12/02/2004 | WO2004042064A3 Disorders of lipid metabolism |
| 12/02/2004 | WO2004027020A3 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 12/02/2004 | WO2004023490A3 Fluid delivery for scanning probe microscopy |
| 12/02/2004 | WO2004014212A3 Self-assembled muscle-powered microdevices |
| 12/02/2004 | WO2004013308A3 Maxs as modifiers of the axin pathway and methods of use |
| 12/02/2004 | WO2004012585A3 Electrophysiology assay methods |
| 12/02/2004 | WO2004009833A3 Test systems for detecting inhibitors of inositol phosphate kinases and use of these inhibitors for the prophylaxis or therapy of proliferative diseases |
| 12/02/2004 | WO2004009765A3 Strategies for gene expression analysis |
| 12/02/2004 | WO2003095667A3 Autoimmune conditions and nadph oxidase defects |
| 12/02/2004 | WO2003089605A3 Method of creating a library of bacterial clones with varying levels of gene expression |
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1 |
| 12/02/2004 | WO2003073817A3 Rapid and sensitive detection of cells and viruses |
| 12/02/2004 | WO2003073066A3 Reagents and methods for assaying bacillus anthracis lethal factor protease |
| 12/02/2004 | WO2003064665A3 Viral vector |
| 12/02/2004 | WO2003044161A3 Gene amplification and overexpression in cancer |
| 12/02/2004 | WO2003027240A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor |
| 12/02/2004 | WO2003014298A3 Full-length prostate selective polynucleotides and polypeptides |
| 12/02/2004 | WO2003006482A3 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 12/02/2004 | WO2002078512A8 Blood glucose tracking apparatus and methods |
| 12/02/2004 | WO2002068583A3 Enzymes having dehalogenase activity and methods of use thereof |
| 12/02/2004 | WO2002051981A3 Defects in periaxin associated with myelinopathies |
| 12/02/2004 | US20040244068 Determining the life-stage of companion animals using immune status indicators or measuring cell populations |
| 12/02/2004 | US20040243318 Microbe examining device and method |
| 12/02/2004 | US20040242601 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 12/02/2004 | US20040242532 Drug screening for and use of enzyme inhibitors of ADP-glucose pyrophosphorylase and glycogen synthase; adenosine alpha -P-boranodiphosphoglucose; bactericides |
| 12/02/2004 | US20040242521 Thio-siRNA aptamers |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242512 Novel vectors for animal cells and utilization thereof |
| 12/02/2004 | US20040242511 Method |
| 12/02/2004 | US20040242510 Methods and compositions for detecting colon cancers |
| 12/02/2004 | US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor |
| 12/02/2004 | US20040242484 Specific polypeptides, useful as nematocides |
| 12/02/2004 | US20040242462 Detecting that individual's Tob gene, transcript and/or protein and comparing with normal Tob gene, transcript and/or protein, differences present indicating that the probability of that individual suffering from amnesia |
| 12/02/2004 | US20040241880 Enhancing fluorescent signal of microarrays via acetonitrile/degradation inhibitor deposition; nucleic acid analysis |
| 12/02/2004 | US20040241869 Multicompartment device for monitoring temperature changes in chemical and biochemical reactions; noninvasive electrothermometry; screening, identifying, and ranking drug candidates |
| 12/02/2004 | US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution |
| 12/02/2004 | US20040241850 Glucosyltransferases which glucosylate abscisic acid |
| 12/02/2004 | US20040241848 Method of detecting microorgan ISMS using labelled electron acceptors |
| 12/02/2004 | US20040241830 Screening drugs targeting the D-alanine branch of mycobacterial peptidoglycan biosynthesis; bioassay; microbiocides; genetic vaccines |
| 12/02/2004 | US20040241828 Automated process for detecting pathogenic organisms in water |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241825 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |
| 12/02/2004 | US20040241824 Identifying nucleotide sequences polymorphisms and/orvariations between methicillin resistant and sensitive bacteria; diagnosis and treatment of infection; using polymorphic sequences to distinguish between bacterial phenotypes; genomics |
| 12/02/2004 | US20040241823 Method and kit for the diagnosis of ulcerative colitis |
| 12/02/2004 | US20040241818 Assay |
| 12/02/2004 | US20040241811 Enzymatic method of producing 4-O-B-D-galactopyranosyl-D-xylose, 4-O-B-D-galactopyranosyl-D-xylose obtained using said method, compositions contain same and the use thereof in evaluating intestinal lactase |